Many biopharma companies rely on firmographic segmentation—categorizing prospects by company size, industry, or development stage—to guide their marketing and sales efforts. However, these surface-level characteristics rarely explain how organizations make decisions or what outcomes they are trying to achieve. By incorporating behavioral, psychographic, and outcomes-based segmentation, companies can better identify the customers most likely to benefit from their solutions, tailor messaging to stakeholder priorities, and improve commercial performance. Effective segmentation goes beyond who a company is—it reveals why they buy, how they decide, and what success looks like for them.